RePORT International Resources

To address the need for trustworthy and scientifically based information focused on providing a basic understanding of science, HANC responded by creating an ad-hoc work group with international membership to develop videos on several important topics. On this page you will find videos and links to additional resources that aim to make understanding science and clinical research easier. Videos include: Why is Science Essential?, Why is Research Important in Science?, Who are Clinical Research Stakeholders?, The Scientific Method, and Regulations and Clinical Research Studies.

This webinar covered Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in persons with TB and how to medically manage these patients.

Unitaid supports in making new health products available and affordable for people in low- and middle-income countries. It identifies innovative treatments, tests and tools, help tackle the market barriers that are holding them back, and get them to the people who need them most – fast. It provides health partners with financial grants to accelerate innovation in global health.

We will have IS relevant webinars monthly led by IS experts on the 3rd Wednesday of the month from 12pm-1pm CT (unless specified). All slides and recordings will be uploaded to this site after the webinar. If you want to know about upcoming webinars, please join the Listserv (https://sites.uab.edu/hivis/join-the-listserv/).

RePORT Indonesia, in partnership with the TB Alliance and the Respiratory Programmatic and Research Institute, have developed Upskill TB, a free online learning platform designed to enhance knowledge and skills in the treatment and management of drug-resistant tuberculosis. The current version has expert-led courses on the innovative BPaL/M regimen.

The RePORT International Long TB project will collect data in a variety of ways. 1. A central REDCap build hosted at Frontier Science. All sites must register for accounts to access this central REDCap build to log participant data. 2. The File Exchange Utility (FEU) hosted at Frontier Science. All sites must register for accounts to access this utility to upload de-identified DIACOM scan files. 3. The Data Submission System (DSS) hosted at Frontier Science. All sites must register for accounts to access this utility to upload information about specimen storage and availability. This guide includes instructions for registering for accounts and for accessing and using these tools.

The VALIDATE Network aims to accelerate vaccine research and development for three groups of complex neglected intracellular pathogens that cause significant mortality and morbidity throughout the world, particularly in low-and-middle-income countries (LMICs): Mycobacteria (causing tuberculosis, leprosy and other diseases), Leishmania (causing leishmaniasis) and Burkholderia pseudomallei (causing melioidosis). A second, important aim of the VALIDATE Network is to facilitate career progression for its members, particularly Early Career Researchers (ECRs), and (recognising career progression inequity) researchers from LMICs and researchers identifying as female and/or non-binary. CALL FOR ROUND 6 AWARDS IS EXPECTED IN DECEMBER 2025

This monthly webinar series covers the research and publishing process. Featuring Sage and external speakers from various disciplines, this series addresses the stumbling blocks every researcher encounters at the beginning of their careers and provides practical and in-depth guidance to help get published. For more information and to register for each webinar, click the links below. All webinars occur at 8 am PT/11 am ET/5 pm CET. You can also watch recordings of the previous webinars in the series by scrolling down to our webinar library, where you can find links to all the recordings and topics available at your fingertips anytime, anywhere.

Deadline: Rolling Weiss Asset Management Foundation invites proposals from organizations and researchers that engage in highly cost-effective work to alleviate human suffering in low- and lower-middle-income countries. Most grants will range from approximately $50,000 to $1.5 million. There is no lower bound, and in exceptional circumstances, grants may exceed $1.5 million.

Application deadline: 25 August 2026 This scheme will support researchers of Black, Bangladeshi and Pakistani heritage in the UK to undertake activities that put them in a stronger position to reach their next career stage within academia. The funding can be used for research or research-adjacent activities, such as training, secondments, and networking. Please refer to the website for the detials

This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding related to human life, health and well being. The applications are opened 3 times a year.

This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and well being. The applications are opened 2 times a year.

This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme. The applications are opened 3 times a year

Wellcome - Grants and Fundings - Searchable Database

This learning platform is custom-built to host high-quality courses developed by the WHO Academy, along with a wide range of quality-approved content from trusted providers. It offers personalized learning pathways, interactive tools, and collaborative features.

Addressing TB requires a multifaceted approach, including awareness raising, risk communication, mobilization, and community engagement. Awareness helps individuals understand TB transmission, symptoms, and prevention, encouraging early detection and treatment. Mobilizing communities supports collective action, combats stigma, and promotes check-ups and vaccinations. Meaningful engagement involves communities in decision-making, fostering trust and access to care. Together, these strategies support prevention, reduce stigma, and advocate for better healthcare access.

Learn how to analyse, interpret, and present routine TB surveillance data and how to make use of your findings to generate hypotheses for further investigation and planning programmatic responses. This course draws on basic principles of epidemiology which are applied to TB surveillance data, also covered in the Understanding and using tuberculosis data handbook. Learners should also consult the Consolidated guidance on tuberculosis data generation and use: module 1: tuberculosis surveillance for an up-to-date set of recommendations. Examples, practice exercises and case studies are based on reported findings from conducting national TB epidemiological reviews which follow a standardized terms of reference, implementation methodology and analytical plan.

This website provides access to the latest WHO recommendations on all aspects of tuberculosis prevention and care. The user can search, filter and cross-tabulate the recommendations through built-in functions. For each individual recommendation one can also access key background information, such as the evidence summaries and the Guideline Development Group decisions underpinning it.

This call to action accompanies the consensus statement on the optimal and early inclusion of pregnant and lactating women in tuberculosis research and specifies the actions that need to be taken to ensure full implementation of the agreed approaches in the statement. The target audience includes product developers and industry, study sponsors, funding agencies, researchers and research networks, regulatory authorities, institutional review boards (IRBs) and ethics committees, national TB and maternal and child health programmes, civil society organizations and affected communities, and health care providers.